AHSG and Insulin resistance: Fetuin-A also exacerbates adipose tissue inflammation and the development of insulin resistance by increasing free fatty acid binding to toll-like receptor 4 (TLR-4) [28], while decreasing adipose tissue PPARγ and adiponectin expression, further reducing its anti-inflammatory and insulin-sensitizing effects.